Lilly Says UK Medical Journal Retracts Prozac Claim

CHICAGO (Reuters) - The British Medical Journal has retracted its controversial claims about drug maker Eli Lilly and Co, its drug Prozac and a potential link to suicide, Lilly said on Thursday.

The journal caused a stir late last year when it said it had evidence, including "missing documents" suggesting a link between the anti-depressant and suicidal behavior and appearing to show Lilly had knowledge of these "troubling side effects."

The medical journal now says its claim that Lilly let documents go missing was not what its authors intended.

"The BMJ is happy to set the record straight and to apologize to Eli Lilly for this statement, which we now retract, but which we published in good faith," the article says, according to the drugmaker.